Research ArticleOpen AccessGoogle Scholar indexed
A Case Report: Calciphylaxis Presenting as Digital Ischemia in Patient with End Stage Kidney Disease on Peritoneal Dialysis
Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA
Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA
Department of Medicine, Mercy Medical Center, Baltimore, MD, USA
- 1 Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA
- 2 Department of Medicine, University of Maryland Medical Center, Baltimore, MD, USA
- 3 Department of Medicine, Mercy Medical Center, Baltimore, MD, USA
Open Journal of Nephrology·Volume 09 (2019)·Pages 49–53·Published 17 April 2019·DOI10.4236/ojneph.2019.92006
Copy link · social · email
Abstract
Calciphylaxis also known as Calcific uremic arteriolopathy (CUA), is a fatal disease with high mortality that mostly affects patients with end stage kidney disease (ESKD) on dialysis. In recent years the incidence of CUA has been increasing among patients on peritoneal dialysis (PD). The exact mechanism and risk factors are not well described.
KeywordsCalcific Uremic ArteriolopathyCalciphylaxisESKDPDHD
- Jeong, H.S. and Dominguez, A.R. (2016) Calciphylaxis: Controversies in Pathogenesis, Diagnosis and Treatment. The American Journal of Medical Sciences, 351, 217-227. https://doi.org/10.1016/j.amjms.2015.11.015
- Harris, C., et al. (2018) Multi-Intervention Management of Calcific Uremic Arteriolopathy in 24 Patients. Clinical Kidney Journal, 11, 704-709. https://doi.org/10.1093/ckj/sfy007
- Nigwekar, S.U., et al. (2014) Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis. Journal of General Internal Medicine, 29, 724-731. https://doi.org/10.1007/s11606-014-2910-1
- Nigwekar, S.U., et al. (2016) A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors. Journal of American Society of Nephrology, 27, 3421-3429. https://doi.org/10.1681/ASN.2015091065
- Brandenburg, V.M., et al. (2017) Calcific Uraemic Arteriolopathy (Calciphylaxis): Data from a large Nationwide Registry. Nephrol Dial Transplant, 32, 126-132.
- Brandenburg, V.M., Cozzolino, M. and Mazzaferro, S. (2014) Calcific Uremic Arteriolopathy: A Call for Action. Seminars in Nephrologyl, 34, 641-647. https://doi.org/10.1016/j.semnephrol.2014.09.007
- Zhang, Y., et al. (2016) Calciphylaxis in Peritoneal Dialysis Patients: A Single Center Cohort Study. International Journal of Nephrology and Renovascular Disease, 9, 235-241. https://doi.org/10.2147/IJNRD.S115701
- Galloway, P.A., et al. (2015) Vitamin K Antagonists Predispose to Calciphylaxis in Patients with End-Stage Renal Disease. Nephron, 129, 197-201. https://doi.org/10.1159/000371449
- Fine, A. and Zacharias, J. (2002) Calciphylaxis Is Usually Non-Ulcerating: Risk Factors, Outcome and Therapy. Kidney International, 61, 2210-2217. https://doi.org/10.1046/j.1523-1755.2002.00375.x
- New, N., et al. (2011) Calcific Uremic Arteriolopathy in Peritoneal Dialysis Populations. International Journal of Nephrology, 2011, Article ID: 982854. https://doi.org/10.4061/2011/982854
- Wang, A.Y., et al. (2005) Important Differentiation of Factors That Predict Outcome in Peritoneal Dialysis Patients with Different Degrees of Residual Renal Function. Nephrology Dialysis Transplantation, 20, 396-403. https://doi.org/10.1093/ndt/gfh331
- Cupisti, A., et al. (2013) Phosphate Control in Dialysis. International Journal of Nephrology and Renovascular Disease, 6, 193-205. https://doi.org/10.2147/IJNRD.S35632